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2 A. INTRODUCTION 
The dynamic approach of  the Regulation setting up the Monitoring Centre 
1.  . Article 18 of  the basic regulation establishing the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA} requires the Commission to report to Parliament 
and the Council on the activities of  the Monitoring Centre after three years of  operation, 
together with proposals, if  appropriate, to modify or extend its tasks taking into account, 
the evolution of  Community powers.  The Commission considers that this report's review 
of  the Centre's activities should be the starting point for plans to meet the European 
Union's medium- and long-term needs.  The regulation's strategy of  responding to 
changing needs reflects the general pattern followed by the joint strategy against drugs 
from the outset. 
2.  The EMCDDA Regulation was adopted when the Community held only a sectoral 
and peripheral remit in respect of  drugs. The nature and scope of  subsequent amendments 
to the Treaties and the scale of  the action developed on this basis serve to heighten the 
importance ofthe Commission's report to Parliament and the Council at a time when the 
drug phenomenon in Europe is growing ever more serious.  This is why the achievement 
ofthe overall objectives ofthe Union's 1995-99 Action Plan should be related to the 
content of  this report, with its focus on the operational goals to be set for the Monitoring 
Centre in the period following 1996-97. 
EMCDDA:  a new instrument in the European drugs war 
3.  Between the mid '80s and early '90s, the European Economic Community and the 
Member States focused increasing attention on the prospects of  more coordinated 
anti-drugs action, which became mandatory with the Treaty on European Union.  The 
new institutional and operational framework in effect since 1 November 1993 has 
fundamentally changed the previous situation.  The anti -drugs campaign is one of  the 
public health goals specified in the EC Treaty and is included among the objectives set by 
the Union Treaty for cooperation in justice and home affairs.  That Treaty also makes 
provision for defining and implementing a common foreign and security policy covering all 
those areas, including drug dependence.  The new framework provides a foundation for 
the multisectoral and multidisciplinary approach ofthe European Union 1995-99 plan 
approved by the Cannes European Council in June 1995.  When the programme was 
approved the Council called for its guidelines to be translated into specific measures with 
the result that as time goes by the Monitoring Centre is embarking stage by stage on its 
appointed tasks.  In December 1995, the Madrid European Council spelled out the ground 
rules for implementing detailed measures in many of  the areas ofthe programme involving 
the Community, the Union and the Monitoring Centre.  In December 1996 a detailed 
programme setting out the action programme for the Centre, reviewing European Union 
3 
,·,, activities in 1996 and assessing the principal medium-term developments was presented to 
the Dublin European Council.  In the list of  priority measures established for 1997, the 
Heads of  State or Government confirmed their wish to see the European Union develop 
as an area of  freedom, security and justice by making full,  coherent use of  Union 
instruments. 
Adaptable programming as a working method 
4.  The need to establish precise objectives and the means to implement them within 
the time limits are crucial to the operation of  the Monitoring Centre.  It should adopt a 
gradual approach, its activities leading from one to another as it attains the priority 
objectives laid down for its operation. 
1  Over the past three years of  work, the basic 
regulation has given priority to the first specific area:  demand and demand reduction. 
5.  According to Regulation (EEC) No 302/93, the tools made available for the 
programme are determined for both the Member States and the Centre.  In this case the 
key tool is Reitox, the European Information Network on Drugs and Drug Addiction. 
The specialist national centres likely to make a useful contribution to the work of  the 
Monitoring Centre should be identified and designated each time a multiannual 
programme is decided.  The same applies to contractual relationships with specialist 
centres, and resources are allocated accordingly. 
New horizons:  1998-2000- the Centre's next working period 
6.  Having focused for the last three years on the question of  demand and demand 
reduction and on policies and strategies, as required by the Regulation, the Centre can 
propose to extend its fields of  activity for the next three-year programme ( 1998-2000) to 
other established priority areas.  Needless to say, if  the Centre is authorized to take up a 
fresh challenge, it will have to strike a balance between the new effort and the action taken 
in the first period so that earlier results and those still awaited can be fully exploited 
without delay. 
7.  The criteria governing choices regarding the expansion of  the Centre should 
include the strict budget constraints which will continue to have an impact on all 
Community finances, including those of  the Centre.  In the light of  these financial 
constraints, funding for the Centre will continue to be limited.  Consequently, its 
operations will have to be exapaned in a balanced manner, keeping the focus on priority 
areas. 
According to the basic Regulation the prlorlty areas to be covered by the Monitoring Centre are:  1.  demand and demand 
reduction;  2.  national and Conununity strategies (with special emphasis on international, bilateral and Conununity policies, 
action  plans,  legislation,  activities  and  agreemeots);  3. international  cooperation  and geopolitics  of supply  (with  special 
emphasis on cooperation programmes and information on producer and transit countries);  4. control of  trade in narcotic drugs, 
psychotropic  substances  and  precursors,  as  provided  for  in the  relevant  present  or future  international  conventions  and 
Community acL~;  S.  implications of  the drugs phenomenon for producer, consumer and transit countries, within areas covered 
by the Treaty, including money laundering. as laid down by the relevant present or future Conununity acts. 
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B. GROUNDS FOR ACTION IN COUNCIL REGULATION (EEC) 302/93 
1.  Like the other nine Community agencies, the Monitoring Centre is a body 
governed by European public law with its own legal personality.  No provision is made for 
it in the Treaties and it was established by secondary Community legislation to perform a 
task specified in its constitutive act. 
2 
Basic objective 
2.  The Centre's objective is to supply the Community and its Member States with 
objective, reliable and comparable data at European level on drugs and drug addiction and 
their consequences, and to give them an overview of  the drugs scene when they come to 
take measures or define courses of  action both in their respective areas of  competence and 
at the level of  the European Union. 
Key links in the Centre's activities 
3.  The Centre's first assignment was to collect and analyse available data from 
different sources, while facilitating exchanges of  information between those involved in 
combating drugs. The Centre's next task was to improve the methodology for the 
comparison of  data, especially by formulating indicators and non binding common 
criteria, which it could recommend as means of  achieving greater uniformity of  the 
measurement techniques used by the Member States and the Community.  The third task 
is to draw up and present an annual report containing its findings on the drug situation 
for the Community and the Member States.  Fourthly, the Centre is required to cooperate 
with European and international bodies and organizations and with non-Community 
countries, thereby helping to improve coordination between national and Community 
action in its areas of  activities. 
4.  The Centre's main tool is Reitox, the European Information Network on Drugs 
and Drug Addiction.  It is a system for collecting and exchanging information and 
documentation concerning drugs, drawing in particular on a human network and its own 
computer system. 
There is a wide range of  reasons for creating the various agencies. ·  There are specific reasons which respond to a number of 
general concerns:  the wish to decentralize certain Community activities, to increase the visibility of  the tasks assigned to them 
by clearly identifying the bodies with their mission, and to respond to the need to develop expertise in certain scientific or 
technical areas  . 
5 C. INVENTORY AND ANALYSIS OF THE CENTRE'S ACTMTIES IN THE 
FIRST THREE YEARS 
Establishment of  the Monitoring Centre 
1.  After 1994, the transitional year when the first components of  the structure were 
put in place (Director, Management Board, etc.), 1995 was a trial year, devoted to 
initiating the tasks entrusted to the Centre.  Its constituent parts were put in place 
(physical infrastructure, human resources).  The tasks and machinery for the Centre were 
identified, and launched in November after adoption ofthe 1995-96 operational 
programme.
3 
Admonistrative arrangements
4 
2.  The Management Board and the Scientific Committee
5 were set up to control the 
Centre's operation.  The Management Board is responsible for decision-making, and the 
Committee has an advisory role, delivers opinions and makes recommendations to it.  One 
ofthe Board's main tasks in 1994-96 was to adopt the Centre's programmes (the first 
three-year work programme for 1995-97, and the annual work programmes for 1995 and 
1996 as subsets of  it, the annual budgets, and the annual general activities report.  The 
Scientific Committee was required to deliver its opinion on scientific matters concerning 
the content of  the work programmes. 
The following took phu:e in the period under review: 
a.  Installation in Lisbon.  The Ilsbon oflkes were inaugurated on 26 September 1995 in the presence among others of 
Mr Vitorino, Chairman of  the European Parliament Conunittee on Civil Liberties and Internal Affairs. and Ms Gradin. 
Member of  the European Conunission. 
b.  The team:  It took some time to fonn the team.  The DireL1or was eleL1ed for a five year term by the Managt.went Board 
in July 1994 and took offke in mid- January 1995. 
c.  Staff:  At the beginningof1995 the staff  complement numbered 14, and by the end ofthe year there were 17 staff 
members.  Following the accession of  three new Member States, 21 established posts were entered in the budget. At the 
end of  1996, the Centre had some 30 staff  of  all categories taken together. Details of  entry into service: 
15.1.1995:  Director+ !A-grade 
February 1995:  Management Board approved 14 posts 
1.3.1995:  5 posts filled (interinstitutional, therefore rapid, recruitment; administrative posts) 
June 1995: 7 additional posts approved by the Management Board (interinstitutional recruitment, early 1996) 
fourth quarter 1995: scientists arrive (after publication in the OJ + selection= minimum 6 months) 
end 1996:  30 posts approved by the Managll!llellt Board and filled. 
Despite the differences in size and tasks the Community decentralized bodies have a basic structure corresponding in general to 
the following outline: 
Management Hoard composed of  representatives of  the Member States and the Commission, and sometimes. of 
persons appointed by Parliament; 
an executive direL1or who is the body·s legal r<.11fesentative; 
a scientilic committee t.-omp<.>sed of  highly qualified experts in the tield in question; 
inkrnal audit is the responsibility of  the Commission Financial Controller or a Controller appointed by the 
Ct>1mnission; 
ex-ternal audit is in the hands of  the Court of  Auditors of  the European Communities. 
An additional body was set up in accordance with the internal rules ofthe Centre: the Steering Committee.  It consists of  the 
Chairman of  the Management Board, the Deputy Chairman and a representative ofthe Commission.  It takes routine decisions 
between meetings of  the Management  Board and prepares the ground for its discussions.  This body started to function on a 
1·cgular hasis in  1996.  AI the same time the Centre's Advisory Committee on Procurement and Contm<.1s (ACPC) wa.• !i<!l up. 
Its ,;omposition is identical to that of  the Steering Committee plus the head of  the Cootre•s Administrati<m Dcpartm<-'111. 
6 .. 
Finance 
3.  The budget for the first full year (1995) amounted to ECU 5 350 000, which 
covered basic setting-up and fitting-out operations and launching the operational 
activities.
6  The budget for 1996 stood at ECU 6 008 000,
7 including a special Community 
subsidy ofECU 168 000 for the pilot study on petty crime associated with drug abuse.  In 
1997, revenue and expenditure will not rise quite so much. 
8  In addition, given the 
budgetary constraints on the Community's finances, and therefore on the Centre's, there . 
can be no question of  a substantial increase in the Centre's budget for 1997-98. 
First three-year programme 1995-97 
1.  Priority topics 
In view of  the priority given to demand and demand reduction, the first three-year 
programme (1995-97), the annual programmes for 1995 and 1996 and the 1995-96 
operational programme were devoted to this topic.  Special attention was directed to the 
epidemiological study of  the incidence, extent and trends of  the drug problem and 
analysis of  the instruments for reducing demand. 
2.  Priority tasks 
The priority tasks stemming from the 1995 work programme concerned (a) identification 
of  the key indicators and essential data;  (b)  identification of  procedures which would 
ensure the quality of the analyses;  (c) establishment of  cooperation with relevant 
international institutions and bodies, and (d) establishment of  cooperation with the main 
groups and research centres concerned. 
The 1996 work programme followed up and developed the 1995 programme, giving more 
emphasis to particular areas ofwork:  (a)  scope for demand reduction;  (b) clarification 
of  the main differences between information concerning demand reduction and 
epidemiology;  (c)  organization and consolidation ofReitox around the objective of 
data-collection;  (d)  establishment of  the structure of  the first annual report on the 
drugs phenomenon in Europe (1995)  . 
In the first budgetary year, the Centre devoted sliglrtly less than two-thirds of  its resources to operational expenditure, about 
20% to staff  expenditure and the rest to operating costs. 
Tho: Centre spent about 43~-<> of  its budget on operating  exp~.'llditure, a little under 40% on staff  expenditure and the rest on other 
opo.:rating  ~'OSts.  However, if  expenditure on scientific staff is regarded as operational expenditure in pr~1ice, distinguishing it 
from administrative stall' expenditure, the percentage allocated to operational expenditure stands at about 60%.  A small 
contingeru:y reserve of  about 0.30% was entered in the budget.  About two-thirds of  the staff  are scientific and technical. that iH 
directly operational (coordination and organization ofRF.ITOX progranune and directly of  the Centre). 
The 1997 budget stands at ECU 6.3 million.  Of  this amount ECU1.3million have been entered in the reserve by the budgetary 
authority.  The structure of  the expenditure shows the clear separation and relationship between administrative expenditure 
(ECU 1 387 000, i.e. 22%) and operational expenditure(ECU 4 912 000, i.e. 78%). 
7 The 1995-96 operational programme sought to implement the first two annual 
programmes; by focusing on the two main material aspects of  the annual programme.
9 
3.  Operations carried out 
Since the Centre did not become operational until the end of 1995, it was not possible to 
embark on the 1995-96 operating programme approved by the Management Board in 
November 1995 until the beginning of 1996.  The Centre's activities carried out up to the 
end of 1996 can be summed up as follows: 
(i)  Epidemiology 
The aim was to (a) develop the framework set up in 1995;  (b)  initiate specific 
activities;  (c)  obtain an overview of  drug consumption in the Union. 
10 
(ii)  Demand reduction 
Preparatory work was done for a data base on demand reduction activities and for 
a study of  their scientific evaluation.  Consultants' advice was frequently sought. 
Meetings and workshops were held to work out the proposed information system. 
(iii)  Other areas 
(iv) 
"' 
II 
A project relating to a pilot study on petty urban deBinquency associated with 
drug consumption in Europe was fully financed by resources from the justice and 
home affairs budget heading (B5-800). 
Reitox 
Work focused on setting up and consolidating the first bases of  the Focal Points 
network
11
- the  15 Member States, the Commission and the Centre (15+  1+1). 
Reitox is composed of 15 national information centres (Focal Points) and the 
Commission Focal Point.  The Lisbon Centre has begun coordinating the action of 
the Focal Points in conjunction with the Member States' authorities and with the 
Coordination of  the Fight against Drugs Unit in the Commission's Secretariat-
General.  Reitox was launched at the first meeting of  the heads ofFocal Points in 
Lisbon on 18-19 May 1995. 
Firstly, the REITOX programme (Programme I);  secondly, the Centre's direct coordination activities (Programme II):  studies, 
consultants work, organization of  scientific meetings and the dissemination, publication, and documentation activities in support 
of  these measures, with a view to improving the relevance, quality and comparability of  existing data. 
(a)  In developing the framework in 1995, the Centre took a~'lion on all the aspects provided for in the 1996 programme. 
The assistance of  consultants and the national Focal Points of  the Reitox netwmk were frequently called on. 
(b)  The specific activities carried out mainly entailed the analysis of  available data, the preparation of  proposals and pilot 
projects to improve data l:ODection methods for the different types of  drugs consumed.  Assistance and advice was 
frequently ohtained from consultants and the Reitox Focal Points. Seminars were organised. 
(c)  Tire attempt to obtain a comprehensive picture of  drug consumption in the Union was based on information collected 
!rom the Focal Points and other European bodies.  It  provided the basis for the epidemiological section of  the first annual 
report- 1995. 
In the first stage a contract was concluded with a firm to carry out tbe following activities:  (a) organization, management and 
coordination relating to implementation of  Programme I of  the 1995-96 operational programme;  {b)  logistics and technological 
support for Programme I of  the 199  5-96 operational programme;  (c) preparation of  a communication link between the Centre, 
the Commission, the Focal Points and other partners;· (d) maintaining technical liaison with the IDA unit in DG III and the 
Focal Point Conunission in the Secretariat-General;  (e)  support tOr- preparation of  the IDA-Reitox dossier in the framewmk of 
Commission financial assistance to the Centre for tbe IDA programme.  In the second stage, now under way, another contract 
has been signed with an information technology consultant to evaluate the suitability of  the tool for fully completing the tasks 
assigned to Reitox:. and to set up the network based on the TEST  A/IDA infrastructure.  · 
8 In 1995-96 Reitox was installed with the following data:  (a)  detailed description 
of  the drugs information structure supplied by the national Focal Point in each 
Member State;  (b)  detailed, standardized and systematic inventory of  the 
Information Maps drawn up by the 15 Focal Points;  (c)  call for proposals from 
the Focal Points to implement the data collection methods ofReitox;  (d) 
analytical inventory of  European Union action in drugs prevention in 1995 
supplied by the Commission Focal Point as the Commission contribution to the 
first annual report on the drugs phenomenon-in Europe. 
The technical work on the network's technology revealed that it was both possible 
and indeed necessary to consolidate a human network as a basis for advancing the 
Centre's work.  This made it possible to define the role of  the national Focal 
Points. The Focal Points were then coordinated by Reitox in Lisbon at the end of 
1996. 
(v)  Documentation 
The Centre carried out many measures to develop its own documentation system. 
The action mainly involved the design and organization of  the Centre's archives, 
setting up a computerized documentation unit and preparing a list of  the current 
drugs and drug abuse legislation in the Member States. Many consultants were 
involved in implementing specific actions to complete this task. 
(vi)  Dissemination of  data and publications
12 
The Centre has published:  (a)  a general report on the Centre's activities in  1995~ 
(b)  a bi-monthly newsletter, Drugnet Europe,  available in English, French, 
German and Portuguese (first issue:  September /October 1996)~ (c) the first 
annual report on the drugs phenomenon in Europe - 1995. 
First report on the drugs phenomenon in Europe - 1995 
4.  The first annual report was published in October 1996.  Given that these annual 
reports are central to the Centre's work, this record of  its achievements in 1994-96 should 
be regarded as a barometer of  the success of  the Centre and as a key to its future 
activities.  The possibilities are assessed in the following chapter. 
12  Between 199S and 1996 the Centre completed 29 studies(to which another29 will be added in 1997) on a wide range ofsubje~1s: 
structures. organi7Ation. flows, infonnation systems,. documentation. archives, methods of  analysis, scientific:: evaluations, 
approaches eontributing to the annual-reports,  demand reduction instruments and activities, d}lUUIIics and prevalenee of 
oonswnption, eommunication and prevention techniques, international cooperative modules. 
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D. EVALUATION  OF THE CENTRE'S ACTIVITIES IN THE FIRST THREE 
YEARS 
Management of the Centre 
1.  The Centre has certainly had to overcome some difficult obstacles.  Apart from 
the intrinsic complexity of  its mission. there was considerable delay in making the 
requisite resources available.  The differences in the Reitox contributions and in the 
Member States' perception ofthe Centre's role did not make the task any easier. 
Nevertheless, the Centre made some headway towards its goals and achieved some 
. results, many only partial;  it has undertaken to complete them before the end of 1997. 
(a)  effectiveness of  dedsion~making  procedures (Management Board and 
Bureau) 
As the Centre's work progressed and expanded, decision-making procedures relating to 
the substance of  the Centre's activities were gradually refined.  With more effective 
interaction between the preparatory body (the Bureau) and the decision-making body 
(Management Board), the hoped-for incisiveness of  the system became more convincing 
early in January 1997, when decisions regarding the 1997 budget and work programme 
and the preparatory work for the new 1998-2000 work programme were all adopted with 
transparency and rigour as regards the issues at stake, the clarification of  priorities and 
the suitability of  instruments  . 
(b)  value added by tbe Scientific Committee 
The Committee was consulted on the key aspects of  the draft three-year and annual 
programmes, but its contributions were barely perceptible.  In general, this body's great 
potential for targeting and developing action should have been mobilized to a greater 
extent.  By drawing on the capabilities available in Commission departments, especially in 
the areas of  R&D and public health, the Committee could bring scientific rigour to the 
discussions and exercise some control over the activities, thus reducing duplication, 
increasing reliability, and consequently improving results, not to mention the credibility of 
the Centre as a whole. 
(c)  efficient organization 
By the end of 1996 the Centre's staff  complement was fully up and running.  The recent 
installation of  two key elements has to be appreciated.  First, the coordination function of 
Reitox provides a focal point for the work:  mobilization of  the system and the effect it is 
expected to have on the structure ofthe national Focal Points should help to generate 
greater fluidity in the organization as a whole.  Next, since the financial department has 
been organized and consolidated, it can be associated with the preparation and follow-up 
of  planned activities and constitute the backbone of  the internal organization.  Now that it 
is operational, it can help to promote transparency and coordination in the interface 
with the Commission as regards the budgetary procedure and its contribution to the 
Management Board, liaison with the Commission's Coordination ofthe Fight against 
Drugs Unit, and management of  the Commission-Reitox Focal Point. 
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Interface with tbe Centre's partners 
2.  The success of  the Centre depends on effective relations with its partners:  the 
European institutions (in particular the Commission) the Member States and other 
subnational and international bodies and organizations. 
(a)  Reitox network 
The stimulus and coordination provided by the Reitox network which the Centre was 
required to organize have become increasingly beneficial as the initial weaknesses have 
been gradually overcome. 
The Centre outlined the priorities and working methods for the future.  With the 
support of  the Centre, Reitox promoted the formulation and use of  ccimmon instruments 
for data collection, storage and exchange.  The operation ofReitox has prompted Member 
States to think about national data collection methods, setting up centres and improving 
data networks. 
The Focal Points revealed a growing need for information flows within the network, 
especially from the Centre to the Focal Points, including the Commission Focal Point. The 
main reason for this need was that until the end of 1996 there was no fixed contact point 
in the structure of  the Centre responsible for coordinating Reitox.  In addition, the 
structure of  the network (human and computerized) and nature of  the national Focal 
Points' tasks in relation to the central point were not clarified until the beginning of 1997. 
Only today has the Centre finally defined with sufficient rigour the criteria for 
designating the national Focal Points forming the network.  There was some uncertainty 
due to the delay in implementing the basic regulation, and this was corroborated by 
subsequent discussions in the Management Board early in 1997.  A solution to their start-
up difficulties was brought within reach at the Focal Points meeting in September 1996. 
The meeting laid the bases for common key criteria for the definition of  a national Focal 
Point.  Its function is twofold:  to collect and disseminate information (quality, synthesis, 
development) to the Centre and the other Focal Points and to be responsible for projects 
aimed at improving and developing infonnation (multidisciplinary, promotion of  high 
standards, subsidiarity). 
The main outstanding item is to consolidate the Member States' commitment (including 
financial commitment) to the Focal Point, and to make the Commission Focal Point fully 
operational.  In December 1996 the latter inaugurated its functional and computerized 
structure, which is designed to make the information collected available to the Centre. 
11 .i 
b.  European Institutions 
Like the Europol  Drugs Unit, the Monitoring Centre was actively associated with the 
Group of  Experts on Drugs which produced reports presented in.turn by the Council and 
the Commission to the Madrid European Council and the Dublin II European Council. 
The contributions to the detailed programme presented at the Dublin II summit confirmed 
the value of  the dual approach involving the reduction ofboth demand and supply in joint 
action by the Commission and the Member States. 
For their part, the European institutions sent the Monitoring Centre proposals for action 
on specific topics (petty urban delinquency associated with drug abuse, quantities of  drugs 
fixed by Member States to distinguish personal use from trafficking, alternatives to prison 
in the event of  conviction, trends in national anti-drugs policies, R&D on the drugs 
phenomenon, etc,).  Since most ofthese proposals were in addition to its work 
programme, the Centre had to make a choice.  It adopted a balanced approach in general 
and although it showed it was responsive to these issues, in the interests of  consistency it 
concentrated its financial and human resources on the gradual completion of  its work 
programme. 
c.  International organizations 
The Centre concentrated its efforts on establishing contact with the Council ofEurope's 
Pompidou Group, mainly in the field of  epidemiology.  Relations with the 
United Nations International Drug Control Programme (UNDCP) were established with 
the appointment of  a liaison officer in 1996.  Initial contacts have been made with the 
Europol Drugs Unit, whilst the relations established with the World Health Organization, 
the World Customs Organization and Interpol led these bodies to participate in the first 
report on the drugs phenomenon in 1995.  Since the reference period was essentially 
devoted to the launching of  operations, it seemed wise to adopt a gradual approach in this 
area, even though epidemiology and demand reduction in particular are undoubtedly 
promising areas to investigate in the fight against drugs. 
Strengths and weaknesses of the first annual report on the drugs phenomenon in 
Europe -1995 
3.  The 1995 report
13 is the first stage in an unprecedented effort to lay the foundations 
for a comprehensive view of  the extremely complex and stratified picture of  the drugs 
phenomenon in Europe.  Only the progress made throughout the 1996 programme, and 
especially the progress expected in 1997, makes it possible to produce the overall view 
required by the European Union.  The Centre naturally had first to collect existing data 
before it could be improved and valid comparisons made.  The data was collected in the 
first three years and work started on improving it with a view to comparison and 
harmonization.  In the next period, it should become possible to draw comparisons from 
whatever date is actually comparable.  AJthough much of  the data is only partial, the 1995 
report reveals the key aspects of  the demand phenomenon and offers an insight into the 
main demand reduction activities.  A study of  the report reveals certain lacunae:  the 
13  Two earlier reports were drawn up by Connnission depanments in 1990 and 1994 on the situation with respect to drugs demand 
in the then twelve Member States of  the European (Economic) Connnunity. 
12 . central message is that there is a crying need to organize existing sources of  information 
on a systematic basis and for specialist centres to process the information. 
(i)  Functions 
a. Data coUection and analysis 
Based on the essential tools (surveys, studies, pilot projects, etc.) the report is the 
direct product of  the Centre's work in this key task. This is particularly true in the 
case of  the first data collated on demand and demand reduction.  The data 
collected on information sources and their structures were also the direct product 
· of  this basic task. 
b.  Improved comparison methods 
The report is less successful in this area.  The main causes are the great variations, 
the multiple factors of  diversity affecting most of  the categories of  data processed, 
and the great difference in the quality of  the instruments in operation in the 
Member States.  There remains a vast unexplored territory in this area, but the task 
has been precisely delineated and the report considers ways of  achieving the 
objective. 
c.  Dissemination 
Dissemination of  information is the other vital function of  the report.  Not only did 
the report appear Iatein the year following the reference year, but the delay in its 
appearance in the eleven official Community languages has been regrettable:  only 
the English version was available at the end of 1996.  Immediate steps should be 
taken to ensure cooperation at all levels between the Monitoring Centre and the 
European Union Translation Centre. 
(ii)  Chapters 
d. Demand and demand reduction 
The report devotes a relatively short chapter to this question although it is a 
priority area.  The general inexperience of  the Reitox Focal Points and initial 
shortage of  clear concepts are probably the main impediments to be overcome 
before the requisite information is available.  However, the basis for systematic 
understanding of  drug demand has been laid.  The requisite epidemiological data 
and specifications have been collected so that the basic information can be made 
available at Union level.  The inc1usion of  less traditional indicators such as 
purity/price ratios and seizures is a positive step.  Although the data collected is 
not always complete, the tool promises to tackle the question on a comprehensive 
basis. A key message stands out from the chapter.  Prevention is a top priority in 
the comprehensive approach to drug prevention, both for national policies and for 
international strategies to combat drug abuse.  Pursuit of  the objectives at each 
stage of  the prevention process promises to help develop the relevant skills, 
facilitate cooperation between the actors involved and promote coordination of 
13 tmtlattves.  The key to success is the availability of  harmonized data.  at · 
European level. 
e.  Anti-drug strategies 
The chapter is proportionally weightier than the chapter on demand and· demand 
reduction.  By plunging into this second area of  activity, the Centre has produced a 
detailed survey ofthe strategies ofthe Member States and of  the European Union. 
It combines many aspects of  an overview and offers decision-makers a frame of 
reference.  It anticipates the Centre's second work priority and adds to its value. It 
emerges that the concept of  demand reduction is used in Europe (and the world) 
to cover a range of  prevention, treatment and rehabilitation measures combined in 
various ways at different times and in different places.  In the European Union, the 
Member States are agreed that the strategies for demand reduction are the joint 
responsibility of  local communities, official and unofficial services and a variety of 
professions and occupations.  The action is predominantly decentralized.  Drug 
prevention is a universally recognized priority, but its impact is difficult to 
measure. 
f  Information sources 
The crucial challenge was to ensure the accountability, reliability and comparability 
of  information to provide the basis on which the Member States and Union 
institutions could make informed strategic and political choices.  Outside the 
epidemiology contest, where the quality of  the data is generally adequate, the 
diversity and irregularity of  the information is one of  the main obstacles. The choice 
of  common definitions and classifications, together with better transmission 
systems, are as vital as ever!  The long-term aim will be international consistency. 
g. Information structures 
The Reitox network is not yet performing its function to the full.  In 1997 the 
system is expected to produce transparent common bases and unified views so 
that the Focal Points can act as links in an efficient interlocking network providing 
the impetus for structures, collection and flows.  The network of  documentation 
centres supporting Reitox should be developed:  progress should be mapped out 
for their field of  action and interconnections. 
The Monitoring Centre's publishing activities 
4.  There were certain weaknesses in the implementation ofthe 1995-96 operational 
programme.
14  Whatever the reasons for the absence of  publications, scientific works for 
the general public and their promotion played and will play a big part in enhancing the 
European citizens' perception of  the Centre.  Great care should be taken to ensure 
publishing is covered in budgetary terms. 
14  Provision was made to produCil the bi-monthly newsletter in the eleven official Community languages, but it appears in only fiJUr. 
The publications specially intended for professionals and the scientific studies provided for in the 1995-96 operational programme 
will be produced in 1997.  As for the publications for the Focal Points and the specialist bodies also provided for in the 1995-96 
operational programme, only the annual epidemiological report will be produced later.  The delays were due to the late adoption of 
programmes. the bottleneck in translation and quality requirements: 
14 E.  CLOSING REMARKS 
1.  Key aspects of the servic~ expected of the Centre 
a.  Functional priorities 
The first annual report (1995) is the first step in the right direction.  To obtain 
adequate data on the drug phenomenon in the Union, top priority should be given 
to the following three areas of  work:  (a)  completing and managing a database on 
demand reduction activities in cooperation with the Reitox Focal Points; 
(b) establishing the linguistic equivalents for demand and demand reduction; 
(c) progress in assessing the evaluation methods of  drug prevention projects. 
The Centre must rapidly develop its planning capacity and its ability to stick 
closely to the programme adopted. 
b.  Systemic priorities 
The basic regulation does not precisely define the Focal Points of  the Reitox 
network.  The Centre, together with the Commission among others, should work 
towards determining the precise rights and duties of  the national Focal Points, in 
terms ofboth organization and budget.  Reitox is the key tool which the Centre 
must develop to carry out its tasks.  The main requirement is for the Member 
States to improve the quantity and quality of  the operation of  each of  the Focal 
Points, which will have to play a permanent and structural role in the network. 
The Commission will consolidate and develop the Commission Focal Point to 
ensure that it slots neatly into the 15 + 1 + 1 network and contributes to the results 
expected of  it. 
c.  Visibility:  a vital condition 
Publication of  annual reports on the drug phenomenon is the keystone of 
dissem;,nation activity.  Priority should be given to three main points:  readability 
of  the <iocument, simultaneous availability in the ll  official Community 
languages, and pubiication early in the year following the reference year.  The 
Centre should take action without delay. This is crucial to the citizen's perception 
of  the Ceptre. Publications should take a neutral tone to ensure that the European 
public finds acceptable any measures the Union might propose on the basis of  the 
objective, reliable and comparable data these publications are supposed to contain. 
Transparency should be the aim of  all the Centre's activities, especially with 
respect to the numerous studies under way, with a view to promoting the 
development of  appropriate synergies with on-going action in the Commission. 
Action to promote visibility should include data produced by the Centre's partners 
in the light of  the Union's priorities:  selective dissemination of  this data and of 
15 ,, 
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data concerning tasks 3, 4 and 5 ofthe.Centre's work might be valuable, . 
depending on the specific projects to which the Union decides to devote the 
Centre's potential. 
d.  Targeting European Union priorities 
The Community must work to attain rapid synergy in a number of  areas reflecting 
Union priorities.  In general a dual approach should be adopted to the issues of 
reduction of  drug demand and of  supply, for example by pursuing the work on 
cross-referencing medical-social and criminal data started by the Centre.  More 
specifically, priority should be given to achieving the best possible coordination 
between the Centre's work and the following main Community measures: 
(a) implementing the new Community action programme on the prevention of 
drug dependence (1996-2000);
15  (b)  continuing the PHARE/drugs programme 
promoting economic integration with central and eastern European countries and 
the TACIS programme for the new independent states, both programmes being 
coordinated by the Commission;  (c)  implementing the Community's fourth RTD 
framework programme (1994-98) and preparation ofthe fifth programme; 
(d) implementing the TESTA/IDA systems for electronic data interchange 
between administrations.  In particular, the inclusion in the Reitox network of 
central European countries and Cyprus should be considered as soon as possible. 
The question of  new synthetic drugs, which will be targeted once the European 
Union strategy in this area is finalized, will require full cooperation from the 
Centre. 
At international level, 
16 marked progress in these areas will accompany 
developments in the Centre's relations with the UNDCP and with the Council of 
Europe's Pompidou Group. Where necessary, it might be useful to initiate 
contacts with regional bodies outside the European Union, such as the 
Inter-American Drug Abuse Control Commission (IDAC).  Attention should be 
given to cooperation with Europol. 
2.  Conclusions 
a.  Relevance of the tasks assigned to the Monitoring Centre 
In the light ofthe evaluation ofthe Centre's work from 1994 to 1996 on the basis 
of  Council Regulation (EEC) 302/93, having regard to the changes in the Treaties 
and the development of  European Union action, the Commission considers there is 
"'  no need to adapt or extend the tasks of  this decentralized Community body.  The· 
Centre should develop its actitivies in priority areas in the light of  current and 
foreseeable Union budgetary constraints. 
The work programme: wus adopted <m  16 D.:cc:mber 1996 and launched on 30 January 1997  .. 
'rh.: following dates should be noted in particular:  the special session of  the United Nations General Assembly on drugs in June 
1998, and the pan-European ministerial meeting planned by the Council of  Europe's Pompidou Group in May 1997. · 
16 b.  Continuing importance of priority 1 - Demand and demand reduction, and 
the rising importance of priority 2-National and Community strategies 
and policies 
Given its positive assessment of  the Centre's work overall in the first three years of 
· activity, the Commission stresses that it is important for Parliament and the 
Council to ensure that the Centre's tasks are kept out of  the political arena, which 
should continue to be reserved for the Union's institutions. 
·  c.  Increased coordination with the Union's institutions and bodies 
The Commission plans to pursue this goal by working towards closer cooperation 
between the Centre's activities and the activities of  its own departments, not 
forgetting to develop cooperation between the Centre and the Statistical Office of 
the Europ~  Communities within the framework of  the current statistics 
programme.  The European Union's 1995-99 action programme on drugs will 
require such direct cooperation, given the priorities emerging for the remaining 
period of  its implementation. 
• 
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